Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
Clinical trial NCT02540356 · TERMINATED
Trial details
- NCT number
- NCT02540356
- Sponsor
- Baxalta now part of Shire
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-02
- Primary completion
- 2016-05-26
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.